Vertex Pharmaceuticals (VRTX)

Add to Watchlists
Create an Alert
110.04 +0.13  +0.12% NASDAQ Oct 30, 10:28AM BATS Real time Currency in USD

Vertex Pharmaceuticals Cash from Financing (TTM):

113.35M for June 30, 2014

View 4,000+ financial data types

View Full Chart

Vertex Pharmaceuticals Cash from Financing (TTM) Chart

Export Data
Save Image

Vertex Pharmaceuticals Historical Cash from Financing (TTM) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 113.35M
March 31, 2014 237.44M
Dec. 31, 2013 180.88M
Sept. 30, 2013 169.20M
June 30, 2013 164.34M
March 31, 2013 144.54M
Dec. 31, 2012 172.20M
Sept. 30, 2012 -15.61M
June 30, 2012 -3.694M
March 31, 2012 -86.36M
Dec. 31, 2011 -124.24M
Sept. 30, 2011 68.19M
June 30, 2011 446.62M
March 31, 2011 401.06M
Dec. 31, 2010 425.06M
Sept. 30, 2010 954.27M
June 30, 2010 686.37M
March 31, 2010 687.98M
Dec. 31, 2009 999.01M
Sept. 30, 2009 474.06M
June 30, 2009 568.43M
March 31, 2009 547.43M
Dec. 31, 2008 620.74M
Sept. 30, 2008 617.75M
June 30, 2008 360.39M
   
March 31, 2008 378.44M
Dec. 31, 2007 -10.19M
Sept. 30, 2007 -6.615M
June 30, 2007 345.64M
March 31, 2007 347.05M
Dec. 31, 2006 365.86M
Sept. 30, 2006 367.20M
June 30, 2006 59.12M
March 31, 2006 219.04M
Dec. 31, 2005 197.46M
Sept. 30, 2005 185.29M
June 30, 2005 172.43M
March 31, 2005 -7.993M
Dec. 31, 2004 -8.626M
Sept. 30, 2004 4.576M
June 30, 2004 14.64M
March 31, 2004 26.40M
Dec. 31, 2003 37.47M
Sept. 30, 2003 27.44M
June 30, 2003 19.30M
March 31, 2003 23.27M
Dec. 31, 2002 13.84M
Sept. 30, 2002 -9.424M
June 30, 2002 -8.919M
March 31, 2002 -11.02M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Get data for
Advertisement

VRTX Cash from Financing (TTM) Benchmarks

Companies
Gilead Sciences -274.75M
Regeneron Pharmaceuticals 146.66M
Amgen 6.995B

VRTX Cash from Financing (TTM) Range, Past 5 Years

Minimum -124.24M Dec 2011
Maximum 999.01M Dec 2009
Average 295.82M

VRTX Cash from Financing (TTM) Excel Add-In Codes

  • Metric Code: cash_financing_ttm
  • Latest data point: =YCP("VRTX", "cash_financing_ttm")
  • Last 5 data points: =YCS("VRTX", "cash_financing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.